MANLEY; Paul William

Patent Applications and Registrations

Patent applications and USPTO patent grants for MANLEY; Paul William.The latest application filed is for "compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1".

Company Profile

0.36.64

MANLEY; Paul William - Arlesheim CH
Manley; Paul William - Basel N/A CH
MANLEY; Paul William - Ariesheim CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20180134695 - FURET; Pascal ; et al.	2018-05-17
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,896,444 - Furet , et al. February 20, 2	2018-02-20
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,458,112 - Furet , et al. October 4, 2	2016-10-04
Benzamide Derivatives For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20160200705 - FURET; Pascal ; et al.	2016-07-14
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20160185733 - FURET; Pascal ; et al.	2016-06-30
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,340,537 - Furet , et al. May 17, 2	2016-05-17
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,315,489 - Furet , et al. April 19, 2	2016-04-19
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,278,981 - Furet , et al. March 8, 2	2016-03-08
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20150183801 - Furet; Pascal ; et al.	2015-07-02
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20150141427 - Furet; Pascal ; et al.	2015-05-21
Benzamide Derivatives For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20150126485 - Furet; Pascal ; et al.	2015-05-07
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20140343086 - DODD; Stephanie Kay ; et al.	2014-11-20
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 8,829,195 - Dodd , et al. September 9, 2	2014-09-09
Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-- 2-ylamino)phenyl]-benzamide App 20140051853 - Burger; Hans Michael ; et al.	2014-02-20
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20130310395 - DODD; Stephanie Kay ; et al.	2013-11-21
Compounds and compositions as protein kinase inhibitors Grant 8,552,002 - Ding , et al. October 8, 2	2013-10-08
Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-- 2-ylamino)phenyl]-benzamide Grant 8,513,256 - Burger , et al. August 20, 2	2013-08-20
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity Grant 8,445,479 - Griffin , et al. May 21, 2	2013-05-21
Staurosporine Derivatives As Inhibitors Of Flt3 Receptor Tyrosine Kinase Activity App 20120252785 - GRIFFIN; James Douglas ; et al.	2012-10-04
Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino)phenyl]-benzamide App 20120142697 - Burger; Hans Michael ; et al.	2012-06-07
N-Oxides of n-Phenyl-2-pyrimidine-amine Derivatives App 20110294820 - Bornsen; Klaus Olaf ; et al.	2011-12-01
Phthalazine derivatives with angiogenesis inhibiting activity Grant 8,034,814 - Bold , et al. October 11, 2	2011-10-11
Staurosporine Derivatives as Inhibitors of FLT3 Receptor Tyrosine Kinase Activity App 20110224194 - Griffin; James Douglas ; et al.	2011-09-15
Inhibitors Of Tyrosine Kinases App 20110218187 - BREITENSTEIN; Werner ; et al.	2011-09-08
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity Grant 7,973,031 - Griffin , et al. July 5, 2	2011-07-05
Phthalazine Derivatives with Angiogenesis Inhibiting Activity App 20110130399 - BOLD; Guido ; et al.	2011-06-02
N-oxides Of N-phenyl-2-pyramidine-amine Derivatives App 20100222362 - Bornsen; Klaus Olaf ; et al.	2010-09-02
Compounds And Compositions As Protein Kinase Inhibitors App 20100048539 - Chianelli; Donatella ; et al.	2010-02-25
Pyrimidineamide derivatives and the use thereof Grant 7,655,669 - Manley , et al. February 2, 2	2010-02-02
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases Grant 7,652,022 - Floersheimer , et al. January 26, 2	2010-01-26
Inhibitors Of Tyrosine Kinases App 20090286821 - Breitenstein; Werner ; et al.	2009-11-19
N-oxides Of N-phenyl-2-pyrimidine-amine Derivatives App 20090239879 - BORNSEN; Klaus Olaf ; et al.	2009-09-24
Use Of C-src Inhibitors Alone Or In Combination With Sti571 For The Treatment Of Leukaemia App 20090227608 - Donato; Nicholas J. ; et al.	2009-09-10
N-oxides of N-phenyl-2-pyrimidine-amine derivatives Grant 7,557,105 - Bornsen , et al. July 7, 2	2009-07-07
Phthalazine Derivatives with Angiogenesis Inhibiting Activity App 20090076003 - Bold; Guido ; et al.	2009-03-19
Salt Forms of 4- (4-Methylpiperazin-1-Ylmethyl) -N- [4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl]- Benzamide App 20080249104 - Burger; Hans Michael ; et al.	2008-10-09
Inhibitors Of Tyrosine Kinases App 20080188451 - Breitenstein; Werner ; et al.	2008-08-07
Phthalazine derivatives with angiogenesis inhibiting activity Grant 7,399,761 - Bold , et al. July 15, 2	2008-07-15
N-phenyl-3-pyrimidine-amine derivatives Grant 7,329,661 - Buerger , et al. February 12, 2	2008-02-12
4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives Grant 7,326,699 - Capraro , et al. February 5, 2	2008-02-05
N-phenyl-2-pyrimidine-amine Derivatives App 20070265292 - Buerger; Hans Michael ; et al.	2007-11-15
Use Of C-src Inhibitors Alone Or In Combination With Sti571 For The Treatment Of Leukaemia App 20070149539 - Donato; Nicholas J. ; et al.	2007-06-28
Inhibitors of tyrosine kinases App 20070093506 - Breitenstein; Werner ; et al.	2007-04-26
Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemia App 20070027167 - Donato; Nicholas J. ; et al.	2007-02-01
Inhibitors of tyrosine kinases Grant 7,169,791 - Breitenstein , et al. January 30, 2	2007-01-30
Anthranilic acid amides and the use thereof as medicaments Grant 7,122,547 - Huth , et al. October 17, 2	2006-10-17
N-phenyl-2-pyrimidine-amine derivatives App 20060223818 - Buerger; Hans Michael ; et al.	2006-10-05
Phthalazine derivatives for treating inflammatory diseases App 20060217388 - Bold; Guido ; et al.	2006-09-28
Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors App 20060178409 - Bold; Guido ; et al.	2006-08-10
Inhibitors of tyrosine kinases App 20060167015 - Breitenstein; Werner ; et al.	2006-07-27
Novel pyrimidineamide derivatives and the use thereof App 20060142577 - Manley; Paul William ; et al.	2006-06-29
Anthranilic acid amide derivatives and their pharmaceutical use App 20060128684 - Bold; Guido ; et al.	2006-06-15
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia App 20060074094 - Donato; Nicholas J. ; et al.	2006-04-06
N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20060074112 - Altmann; Karl-Heinz ; et al.	2006-04-06
N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF Grant 7,002,022 - Altmann , et al. February 21, 2	2006-02-21
Three-dimensional structure of c-Abl App 20060030017 - Fendrich; Gabriele ; et al.	2006-02-09
N-oxyde of n-phenyl-2-pyrimidine-amine derivatives App 20050209452 - Bornsen, Klaus Olaf ; et al.	2005-09-22
Phthalazine derivatives for treating inflammatory diseases App 20050176711 - Bold, Guido ; et al.	2005-08-11
Phthalazine derivatives for treating inflammatory diseases Grant 6,911,440 - Bold , et al. June 28, 2	2005-06-28
Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors App 20050096356 - Bold, Guido ; et al.	2005-05-05
VEGF receptor tyrosine kinase inhibitors Grant 6,878,720 - Altmann , et al. April 12, 2	2005-04-12
Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity App 20050020570 - Griffin, James Douglas ; et al.	2005-01-27
Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemia App 20040248906 - Donato, Nicholas J ; et al.	2004-12-09
Anthranilic acid amides and pharmaceutical use thereof App 20040248947 - Bold, Guido ; et al.	2004-12-09
Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase App 20040209894 - Bold, Guido ; et al.	2004-10-21
N-aryl (THIO) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20040198782 - Altmann, Karl-Heinz ; et al.	2004-10-07
4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives App 20040180911 - Capraro, Hans-Georg ; et al.	2004-09-16
Phthalazine derivatives with angiogenesis inhibiting activity App 20040180899 - Bold, Guido ; et al.	2004-09-16
Oxazolo-and furopyrimidines and their use in medicaments against tumors App 20040152892 - Bold, Guido ; et al.	2004-08-05
Phthalazine derivatives for treating inflammatory diseases App 20040142934 - Bold, Guido ; et al.	2004-07-22
N-phenyl-2-pyrimidine-amine derivatives App 20040102453 - Buerger, Hans Michael ; et al.	2004-05-27
Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase Grant 6,706,731 - Bold , et al. March 16, 2	2004-03-16
Phthalazine derivatives for treating inflammatory diseases Grant 6,686,347 - Bold , et al. February 3, 2	2004-02-03
2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors Grant 6,624,174 - Manley , et al. September 23, 2	2003-09-23
Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase App 20030158409 - Bold, Guido ; et al.	2003-08-21
Isoquinoline derivatives with angiogenesis inhibiting activity Grant 6,608,071 - Altmann , et al. August 19, 2	2003-08-19
N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20030064992 - Altmann, Karl-Heinz ; et al.	2003-04-03
2-Amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors App 20030032656 - Manley, Paul William ; et al.	2003-02-13
Phthalazine derivatives for treating inflammatory diseases App 20030013718 - Bold, Guido ; et al.	2003-01-16
VEGF receptor tyrosine kinase inhibitors Grant 6,448,277 - Altmann , et al. September 10, 2	2002-09-10
N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors App 20020019414 - Altmann, Karl-Heinz ; et al.	2002-02-14
Isoquinoline derivatives with angiogenesis inhibiting activity App 20020010181 - Altmann, Karl-Heinz ; et al.	2002-01-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.